Drug recall · May 17, 2017
Mozobil recall
Why: Labeling: Incorrect or Missing Package Insert
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation 500 Kendall Street, Cambridge, MA 02412 USA NDC: 0024-5862-01
- Lots / codes
Lot #: 5RZ001C, 5RZ001D; Exp. 04/18
- Quantity
- 2133 vials
- Company
- Sanofi-Aventis U.S. LLC, Bridgewater, NJ
- Distribution
- Nattionwide
- Initiated
- September 1, 2016 · Voluntary: Firm initiated
- Classified
- May 11, 2017
- Reported
- May 17, 2017
- Ended
- February 15, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Plerixafor
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.